Real Money January 12, 2022
Kevin Curran

As M&A investments could hit $400 billion this year, watch for buys in health technology and data, biotech, pharma and medical devices.

The year 2021 went out with a bang for health care M&A action, with major tech companies getting in on the action — but this year should see lots more buys ahead with hundreds of billions of dollars waiting to be spent, according to several experts.

“‘Healthtech’ is a natural target for more consolidation today on the basis that the space exhibits the classic advantages of scale, yet most companies are still-underscaled, such that larger players can bring the broader solution to fruition and achieve the natural scale advantages,” Cody Powers, a partner and principal at management consulting...

Today's Sponsors

Patient Bond
Institute for Healthcare Improvement

Today's Sponsors

Oliver Wyman
Patient Bond

Today's Sponsor

Patient Bond

Topics: Mergers & Acquisitions / JV, Trends
2022 Will Be a More Challenging Year for Healthcare Acquisitions
Change Healthcare mulling sale of its ClaimsXten arm to secure federal OK for UnitedHealth merger
70% of healthcare execs expect M&A activity to rise this year
J&J eyes “tuck-in deals” as consumer health spinoff nears
Podcast: Piecemeal: Health Care Consolidation and Independent Primary Care